TUESDAY, Nov. 16, 2021 (HealthDay News) — For decades, doctors have struggled with the fact that the benefit of any blood-thinning pill came with the added risk of excess bleeding. Now, an experimental anti-clotting pill called milvexian has been found to be effective in patients who had knee replacement surgeryContinue Reading

A woman has rid herself naturally of HIV — but how? Researchers say there’s a second HIV-positive person whose body might have naturally cleared the infection — sparking hope that studying such exceedingly rare events will help lead to a cure. Read more Breast cancer diagnosis raises odds for a-fib.Continue Reading

TUESDAY, Nov. 16, 2021 (HealthDay News) — A rare inflammatory condition associated with COVID-19 in children was more severe in the second wave of patients than in the first, researchers report. For the study, investigators examined the cases of 106 patients with multisystem inflammatory syndrome in children (MIS-C) who arrivedContinue Reading

MONDAY, Nov. 15, 2021 (HealthDay News) — Certain commonly prescribed antidepressants appear to substantially lower the risk of dying among seriously ill COVID-19 patients, a large new study indicates. Selective serotonin reuptake inhibitors (SSRIs) are among the most widely prescribed drugs for the treatment of depression. They include drugs likeContinue Reading

MONDAY, Nov. 15, 2021 (HealthDay News) — People suffering from dangerous abnormal heart rhythms can take matters into their own hands and figure out what is triggering their episodes, researchers report. Folks with atrial fibrillation (a-fib) were able to reduce their episodes of the irregular heartbeat by 40% by identifyingContinue Reading

MONDAY, Nov. 15, 2021 (HealthDay News) — A new and expensive Alzheimer’s drug called Aduhelm is responsible for about half of the $21.60 increase in monthly premiums for Medicare’s Part B outpatient program in 2022, Medicare officials report. The new premium will be $170.10 a month, and the $21.60 boostContinue Reading